Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report
Clinical research study
Current Issue
Editorial Board
Literature Review
Narrative review
Original Article
Research Article
Review Article
Short Report
Surgical techniques
View/Download PDF

Translate this page into:

29 (); 50-59
doi:
10.1016/j.jor.2022.01.002

Thresholds for meaningful improvement in WOMAC scores need to be adjusted to patient characteristics after hip and knee replacement

Technical University Berlin, Department of Health Care Management, Strasse des 17. Juni 135, 10623 Berlin, Germany
Science Office of the Orthopaedic and Joint Replacement Department, Schoen Clinic Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Germany
Orthopedic and Joint Replacement Department, Schoen Clinic Hamburg Eilbek, Dehnhaide 120, 22081, Hamburg, Germany
Faculty of Life Sciences at the Hamburg University of Applied Sciences, Lohbrügger Kirchstraße 65, 21033, Hamburg, Germany
Orthopedic and Joint Replacement Department, Schoen Clinic Neustadt, Am Kiebitzberg 10, 23730, Neustadt in Holstein, Germany
School of Medicine, University of St. Gallen, St. Jakob-Strasse 21, 9000, St. Gallen, Switzerland

∗Corresponding author: Carlos J. Marques. cmarques@schoen-klinik.de

Disclaimer:
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

To calculate unstratified and patient-specific meaningful improvement (MI) and patient acceptable symptom states (PASS) for the WOMAC total score in patients after total hip (THR) or total knee replacement (TKR).

A retrospective observational cohort study. Anchor-based receiver operator characteristics curves were used to estimate MI and PASS thresholds.

Recovery paths were specific to individual characteristics of patients. An unstratified 12-months MI threshold of 28.1 (PASS: 13.3) and 17.8 (PASS: 15.8) for patients after THR and TKR, respectively, would unfairly detect critical recovery paths.

Thresholds for treatment success need to be as patient-specific as possible.

Keywords

THR
TKR
PROMs
MI
VBHC
WOMAC
PASS
Total hip replacement
Total knee replacement
WOMAC
Meaningful improvement
Patient-reported outcomes
Value-based health care
Level of evidence: level III
Prognostic study
PubMed
1

1 Introduction

Total hip (THR) and total knee replacement (TKR) are the ultimate treatment options for patients with end stage hip or knee osteoarthritis who no longer benefit from conservative treatments.1 Simulations indicated that the incidence rates for THR and TKR will increase respectively by 55% and 29% in Germany between 2016 and 2040.2 This expected demand increase presents a new challenge to health care providers and sickness funds. Patient-centered care, sometimes also referred to as value-based health care (VBHC),3 could be the key to overcome this challenge, since it balances the health outcomes that matter to the patients and the costs incurred to achieve those outcomes.4 In this context, patient-reported outcome measures (PROMs) play an essential role, since they allow to measure health conditions and improvements from the patient perspective along the entire patient pathway. The monitoring of patients’ post-surgery improvements with the use of PROMs could enable the early detection of adverse recovery paths. Physicians would get the possibility to intervene and recommend therapy adaptations in order to mitigate revisions and improve long-term treatment outcome.5,6

The implementation of such a monitoring system to detect treatment success or critical recovery paths requires diligently estimated thresholds for single PROM instruments. Several methods can be used to calculate thresholds for meaningful improvements in PROM scores. For instance, the minimal clinically important difference (MCID) represents the minimum change in a PROM score that can be perceived by patients and induces an improvement in his/her health status.7 Moreover, the patient acceptable symptom state (PASS) defines the PROM score that is accepted by the patient to reflect an improvement in his/her health status. The meaningful improvement (MI) represents the change in a PROM score necessary to differentiate between the patients who benefited from the treatment (since the treatment evoked an improvement in health status) and the patients who did not benefit, since their health status did not improve.

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used PROM instrument for patients scheduled for THR or TKR. Literature on thresholds for the WOMAC total score is limited, especially when adjusted to patient-specific factors. While some studies8 calculated unstratified thresholds in the form of MCID and PASS using either a distribution-based,9 anchor-based10 or both methods,11–13 we did not find any literature on thresholds calculated and adjusted to patient-specific factors. As outlined previously, patients' responses to questions may depend on different patient-specific factors, like physical and mental health and sociodemographic features.14 Therefore, the question whether a single MCID score is appropriate for all patients taken a particular instrument was raised.14,15 We believe that PROM thresholds need to be as patient-specific as possible, to be optimally incorporated in informing care decisions and to better reward value.16

The perception of improvement between patients who underwent TKR and THR seems to be significantly different,17 and former studies showed that improvements in PROM scores after surgery are highly dependent on pre-surgery PROM scores.12,18–20

Therefore, the purposes were (1) to identify significant predictors of WOMAC total score improvement after TKR and THR; (2) to build subgroups of patients based on the strongest predictors of WOMAC total score improvement; and (3) to calculate overall and stratified (patient-specific) meaningful improvement (MI) and PASS thresholds for the WOMAC total score for 3- and 12-months follow-up (FU) times in patients who submitted to THR or TKR. The primary question was to investigate whether stratified MI and PASS thresholds are better suitable to map improvements after TKR and THR?

2

2 Patients and methods

2.1

2.1 Study design

This is a retrospective observational cohort study. Reporting of the present study follows the STROBE Statement guidelines for reporting observational studies.21

The Ethics Committee of the Federal State of Hamburg, Hamburg, Germany was informed and approved this study (2021-10582-WF). The study was conducted according to the ethical standards in the 1964 Declaration of Helsinki and its later amendments. Patient informed consent was obtained in both clinics before PROM data collection took place.

2.2

2.2 Patients

For the present purpose the database of two German hospitals, Schoen Clinic Hamburg Eilbek and Schoen Clinic Neustadt, were searched. All patients underwent THR or TKR between January 2016 and December 2018 in one of the hospitals. The data of the patients were included for analyses if the patients submitted for primary TKR or THR; and if preoperative and postoperative PROM data were available. The patients were excluded from analysis if they were submitted for revision arthroplasty or in case PROM data was not available.

During the above-referred time period, 9482 patients underwent THR, of which 8182 submitted for primary THR. From the 4726 patients who filled in the WOMAC questionnaire at admission, only 2638 completed the WOMAC questionnaire at 12-months follow-up (FU), and the EQ-5D-5L at admission and 12-months FU. In the same time period 5747 patients underwent TKR, of which 5377 submitted for primary TKR. Of the 3158 patients who filled in the WOMAC questionnaire at admission, 1728 also completed the remainder of necessary PROM questionnaires.

Patients who submitted for THR were on average 68.4 years old, and majorly female (57%). 74% of the patients were classified into American Society of Anesthesiologists (ASA) group II. Only few patients (3.3%) experienced in-hospital complications. The mean length of hospital stay (LOS) was 7 days. Around 76% of the patients who underwent THR were mobilized during the first 6 h after surgery, in line with the hospitals’ enhanced rehabilitation program (ERP). Similar descriptive data was obtained for the patients in the TKR group. For further details see Table 1.

Table 1 Descriptive statistics of the patients in the TKR and THR groups.
Procedure Total hip replacement Total knee replacement
Variables Observations(percentage) Mean SD Observations (percentage) Mean SD
Age (years) 2,638 68.4 9.6 1,728 69.1 8.7
Women 1,512 (57.3) 967 (56)
ASA
I 270 (10.2) 92 (5.3)
II 1,954 (74.1) 1,291 (74.7)
III and higher 414 (15.7) 345 (20.0)
In-hospital complications 87 (3.3) 59 (3.4)
Rapid recovery in ERP 2,009 (76.1) 1,204 (69.7)
LOS (in days) 2,638 7.0 2.4 1,728 7.1 2.3
Surgery time† (in min) 2,638 46.9 18.5 1,728 57.3 18.8
Elixhauser Comorbidity Score 2,601 3.4 4.6 1,711 3.2 4.7
WOMAC
Admission 2,638 48.1 15.0 1,728 45.1 15.3
3-months FU 1,977 14.1 12.8 1,340 19.5 14.2
12-months FU 2,638 12.9 14.8 1,728 17.5 15.9
Improvements at 3-months FU 1,977 33.8 16.2 1,340 25.0 16.4
Improvements at 12-months FU 2,638 35.2 17.6 1,728 27.6 17.2
EQ-5D-5L
Admission 2,547 0.539 0.281 1,656 0.561 0.283
3-months FU 1,949 0.870 0.165 1,282 0.823 0.176
12-months FU 2,556 0.892 0.169 1,665 0.860 0.167
Improvements at 3-months FU 1,883 0.330 0.289 1,234 0.245 0.276
Improvements at 12-months FU 2,471 0.356 0.293 1,600 1,600 0.284
2.3

2.3 The WOMAC and the EQ-5D-5L questionnaires

The WOMAC evaluates three dimensions (pain, stiffness, and physical function) with the use of 24 items: 5 pain, 2 stiffness and 17 physical function items. It produces three subscale scores, one for each dimension, and a total index score.22 The Likert WOMAC version used in this work23 rates on an ordinal scale of 0–4, with lower scores indicating lower levels of symptoms or physical disability. Each subscale is summed up to a maximum score of 20, 8, and 68 score points, for pain, stiffness and physical function, respectively. The WOMAC total index score is calculated by adding up the three sub-scores. The questionnaire is self-administered and takes 5–10 min to complete.

The EQ-5D-5L is a widely used generic measure of health-related quality of life (HRQoL). It assesses health in five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each of which has five levels of response. Each health state can be assigned an index score based on societal preference weights,24 ranging from less than 0 (where 0 is the value of a health state equivalent to dead) to 1 (the value of full health).

2.4

2.4 Data collection and procedures

PROM data collection took place in both clinics preoperatively at the admission day and at 3- and 12-months FU via postal survey. Despite PROM data collection being part of the routine procedure in both hospitals, it only takes place after patients gave their informed written consent. For organizational reasons, some patients could not participate in the PROM data collection. Additionally, some patients did not give their consent to PROM data collection. These two reasons can explain the number of patients that were admitted for surgery, but whose preoperative PROM data was not available for analysis. Missing data at 3- and 12-months follow-up was due to non-responders in the postal survey.

Basic data such as age and gender were taken from the patients' admission file. Length of stay (LOS), participation in the enhanced recovery program (ERP) and comorbidity index was taken from the hospitals' standard documentation. Additionally, data on the ASA classification score, surgery time and complications were retrieved from the annual compulsory German quality reporting, and PROM data was retrieved from hospitals’ standard PROM collection process. The data of both hospitals was exported and anonymized.

2.5

2.5 Definition of meaningful improvement (MI) and patient acceptable symptom state (PASS) thresholds

The meaningful improvement (MI) threshold assessed in this work is defined as the improvement necessary for a patient to benefit from surgical treatment. While MCIDs, first introduced in 1989 by Jaeschke et al.,25 would reflect the minimum change in the WOMAC score that patients would perceive as improvement of their health status,26 the MI is the WOMAC score improvement necessary to induce a change in Health Status Index that differentiates the patients who did not receive a benefit from surgery from the ones who did, regardless the amount of the improvement.

PASS27 cut points were defined as the WOMAC score at certain points in time, for which patients perceived a minimal improvement of their health status.28 MI and PASS values were calculated for all patients in the THR and TKR groups, and for stratified subgroups for 3- and 12-months FU times.

2.6

2.6 Statistical methods

Descriptive statistics were performed to characterize the sample. Multiple Ordinary Least Squares regression models were used to estimate determinants of WOMAC score improvements between admission and 12-months FU. The WOMAC score improvement was used as dependent variable. Several explanatory variables (preoperative WOMAC score, age, gender, in-hospital complications) were tested simultaneously.

Given the large impact of the preoperative WOMAC score on post-surgery WOMAC score improvement, subgroups were built based on preoperative WOMAC scores. Patients for both procedures (THR and TKR) were clustered in subgroups of 10-WOMAC admission score steps. Due to the need of sufficiently large subgroups, patients with the highest and lowest admission scores were clustered into larger subgroups (0–20; 71–96).

MI and PASS values were estimated with the use of the anchor-based receiver operator characteristics (ROC) curve method.29 ROC curves are often used in medical research to evaluate clinical trials, or to identify thresholds for improvements in outcome measures, such as PROMs.30,31 The plotted ROC curve can be used to determine MI or PASS thresholds that maximize sensitivity and specificity.32 When estimating MI and PASS values in orthopedic settings, the sensitivity and specificity are usually weighted equally.33 In line with Froud et al.,29 who compared available approaches, we have calculated thresholds by minimizing the sums of squares of 1-sensitivity and 1-specificity:threshold=min{(1−sensitivity)2+(1−specificity)2}

This approach picks the point on the ROC curve that is closest to the top left corner on the sensitivity – (1-specificity) plane. For the ROC curve to be plotted, an anchor differentiating between successful treatments and unsuccessful treatment must be set. For both, the calculation of MI and PASS, we set our anchor as an improvement in HRQoL, expressed through the EQ-5D-5L scores:ifEQ−5D−5L(12−monthFU)>EQ−5D−5L(admission)=1ifEQ−5D−5L(12−monthFU)≤EQ−5D−5L(admission)=0

Hence, we implied that for a patient to perceive a meaningful improvement (MI) in health status, a difference in HRQoL between baseline and 12-months FU must be detected. In line with King,34 we tested the correlation between the variable used as anchor and the respective WOMAC score improvements and found that its correlation of 0.49 was larger than the required r = 0.3.

The statistical tests were carried out with the use of the software program Stata and its command rocmic.35

3

3 Results

3.1

3.1 Regression results

The strongest predictor of WOMAC score improvement at 12-months FU was the preoperative WOMAC total score for the patients in both groups (THR and TKR) (Table 2).

Table 2 Regression results on 12-months WOMAC total score improvements.
Procedure Total hip replacement Total knee replacement
Variable Regression Coefficient Standard Error Regression Coefficient Standard Error
WOMAC at admission −0.732*** 0.019 −0.622*** 0.025
Age 0.213*** 0.032 −0.009 0.045
Gender 0.416 0.579 0.905 0.747
ASA Classification - baseline I
II vs. I 2.858** 0.965 4.832** 1.626
III and higher vs. I 7.176*** 1.233 7.926*** 1.818
LOS (in days) 0.311* 0.126 0.846*** 0.171
Surgery time (in min) −0.008 0.018 0.002 0.022
In-hospital complications 3.344 1.819 0.685 2.229
Rapid recovery in ERP −0.576 0.670 −1.649* 0.786
Elixhauser Comorbidity Score −0.044 0.066 −0.081 0.084
Observations 2,366 1,524
R2 0.402 0.302
Adjusted R2 0.399 0.298

Based on the regression results, patients were stratified in subgroups according to their preoperative WOMAC total score (Table 3). The demographic characteristics of the patients in the THR and TKR groups were similar when both procedures were compared. With worse preoperative WOMAC total scores the share of female patients increased considerably, whereas the average age did not change regardless of subgroup association. Patients with worse preoperative scores had more comorbidities, endured more in-hospital complications, faced longer surgery times, stayed longer in the hospital, and were less early mobilized. For details see Table 3.

Table 3 Descriptive statistics by WOMAC admission score groups.
Total hip replacement
WOMAC admission score groups 0–20 21–30 31–40 41–50 51–60 61–70 71–96
Number of observations 113 232 402 657 722 357 155
Age (years) 68.1 69.1 68.5 68.1 68.0 68.3 69.6
Women 38.9% 47.8% 51.0% 56.3% 60.2% 67.5% 68.4%
ASA
I 16.8% 12.5% 13.2% 11.0% 9.4% 5.9% 5.2%
II 75.2% 77.6% 71.9% 76.3% 73.7% 74.2% 65.8%
III and higher 8.0% 9.9% 14.9% 12.8% 16.5% 19.9% 29.0%
In-hospital complications 1.8% 1.3% 2.5% 2.9% 3.6% 4.2% 7.7%
Rapid recovery in ERP 81% 81% 77% 76% 77% 76% 57%
LOS (in days) 6.7 6.5 6.8 6.9 7.0 7.3 8.2
Surgery time (in min) 43.2 45.0 44.3 45.4 48.4 48.2 55.4
Elixhauser Comorbidity Score 3.1 3.3 3.5 3.3 3.3 3.2 4.0
WOMAC
Admission 13.9 26.1 36.0 45.7 55.2 64.4 76.7
Month 3 6.0 8.3 10.7 12.7 16.3 18.6 24.2
Month 12 4.9 6.4 9.8 11.1 14.2 18.7 24.1
Improvements Month 3 8.0 17.9 25.3 33.0 38.9 45.8 53.0
Improvements Month 12 9.1 19.7 26.2 34.7 40.9 45.7 52.6
EQ-5D-5L
Admission 0.779 0.730 0.680 0.624 0.482 0.306 0.137
Month 3 0.940 0.922 0.895 0.881 0.849 0.833 0.804
Month 12 0.942 0.942 0.917 0.908 0.883 0.848 0.801
Improvements Month 3 0.176 0.187 0.218 0.256 0.358 0.528 0.686
Improvements Month 12 0.163 0.211 0.239 0.285 0.401 0.552 0.671
Total knee replacement
WOMAC admission score groups 020 2130 3140 4150 5160 6170 7196
Number of observations 115 183 310 466 401 180 73
Age (years) 70.7 69.5 69.0 69.3 69.1 68.6 66.7
Women 38.3% 43.2% 49.7% 58.2% 60.3% 69.4% 71.2%
ASA
I 9.6% 8.7% 5.8% 5.2% 4.5% 1.7% 2.7%
II 80.0% 75.4% 78.4% 76.0% 74.1% 68.3% 60.3%
III and higher 10.4% 15.3% 15.5% 18.7% 21.2% 29.4% 37.0%
In-hospital complications 0.9% 2.7% 1.0% 3.4% 5.0% 5.0% 6.8%
Rapid recovery in ERP 75% 73% 75% 68% 67% 65% 66%
LOS (in days) 6.7 6.7 7.0 7.0 7.2 7.5 8.1
Surgery time (in min) 52.8 56.5 54.7 56.9 57.7 62.0 65.8
Elixhauser Comorbidity Score 2.7 3.3 3.1 3.3 3.2 3.1 2.4
WOMAC
Admission 14.2 25.8 35.4 45.9 55.0 64.4 76.4
Month 3 10.1 14.0 15.6 19.1 23.1 29.2 28.7
Month 12 7.9 10.5 12.4 17.1 20.2 28.9 31.2
Improvements Month 3 3.9 11.8 19.8 26.8 31.9 35.0 47.4
Improvements Month 12 6.3 15.3 23.0 28.7 34.9 35.4 45.3
EQ-5D-5L Score
Admission 0.792 0.734 0.681 0.592 0.481 0.286 0.169
Month 3 0.897 0.870 0.847 0.834 0.799 0.709 0.758
Month 12 0.944 0.906 0.892 0.872 0.839 0.763 0.745
Improvements Month 3 0.112 0.138 0.169 0.217 0.312 0.444 0.548
Improvements Month 12 0.151 0.170 0.211 0.279 0.361 0.475 0.573

Patients in different preoperative WOMAC total score subgroups experienced different recovery paths (Fig. 1a and b). This affected the 3- and 12-months WOMAC total scores and their corresponding improvements. THR (TKR) patients in the subgroup “71–96” experienced an average improvement from admission to 3-month FU of 53.0 (47.4) score points. Their WOMAC total score improved by 52.6 (45.3) between admission and 12-months FU. In comparison, the patients in the subgroup “0–20” experienced only an average improvement of 8.0 (3.9) points from admission to 3-month FU and of 9.1 (6.3) points between admission and 12-months FU. Patients with higher (worse) WOMAC total scores at admission reported a much higher improvement in comparison to the patients with lower (better) preoperative WOMAC total scores (Fig. 1a and b).

Average and stratified (subgroup) WOMAC total score improvement in the (a) THR and (b) TKR groups.
Fig. 1 Average and stratified (subgroup) WOMAC total score improvement in the (a) THR and (b) TKR groups.
3.2

3.2 Meaningful improvement (MI) thresholds

The estimated overall and stratified MI thresholds by FU-time for the patients in the THR or TKR groups are presented in Table 4. The estimated overall MI for the patients in the THR group presented a WOMAC total score reduction (i.e. an improvement) by 27.0 at 3- and 28.1 at 12-months FU. Whereas the subgroups based on patients age and ASA classification did not show a considerable trend, the MI for the subgroups based on the preoperative WOMAC total score varied significantly. The estimated MI for THR patients with a low preoperative WOMAC total score (0–20) were −8.0 and −9.0 for 3- and 12-months FU, respectively. In contrast, THR patients with medium admission scores (41–50) had considerably larger MI values (−29.0 at 3- and −30.3 at 12-months FU).

Table 4 Estimated (overall and stratified) meaningful improvement (MI) thresholds by FU-time for the patients in the THR and TKR groups
Total hip replacement 3 months 12 months
MI AUC MI AUC
Overall -27.0 0.70 -28.1 0.74
Grouped by WOMAC admission score
0-20 -8.0 0.66 -9.0 0.75
21-30 -14.0 0.61 -19.3 0.72
31-40 -24.5 0.66 -26.7 0.72
41-50 -29.0 0.66 -30.3 0.73
51-60 -36.5 0.69 -37.4 0.70
61-70 -44.0 0.72 -38.0 0.81
71-96 -46.0 0.81 -45.0 0.78
Grouped by age
<=60 -25.0 0.66 -28.0 0.75
60 - 75 -29.0 0.72 -29.0 0.75
>75 -25.0 0.67 -25.6 0.71
Grouped by ASA classification
I and II -29.0 0.69 -29.0 0.73
III and higher -24.5 0.76 -23.6 0.80
Total knee replacement
Overall -18.7 0.67 -17.8 0.73
Grouped by WOMAC admission score
0-20 -4.0 0.63 -6.0 0.68
21-30 -9.3 0.66 -15.0 0.70
31-40 -16.0 0.72 -18.0 0.67
41-50 -27.0 0.63 -26.2 0.73
51-60 -30.7 0.68 -33.0 0.71
61-70 -31.5 0.69 -32.0 0.73
71-96 -37.5 0.79 -32.0 0.91
Grouped by ASA classification
I and II -17.5 0.69 -23.4 0.74
III and higher -20.8 0.61 -17.0 0.68
Grouped by length of stay
fewer than 5 days -5.0 0.88 -24.4 0.80
between 5 and including 7 days -21.6 0.65 -24.1 0.72
between 7 and 9 days -20.8 0.69 -16.0 0.72
longer than 9 days -12.0 0.76 -18.0 0.76

Accuracy, expressed by the area under the curve (AUC), was systematically higher for the estimated MI values at 12-months FU. Whereas almost all estimated MI values for 12-months FU are considered acceptable (≥0.7) or excellent (≥0.8),36 the majority of the estimated MI thresholds for 3-month FU lacked accuracy.

The estimated MI thresholds for patients in the TKR group were lower in comparison to the values of the THR patients, reflecting the general trend visible in Fig. 1b. TKR patients needed to improve by 18.7 and 17.8 WOMAC total scores points to experience a MI in their HRQoL. The estimated MI thresholds for the subgroups showed a similar pattern as for the THR patients. Moreover, when the MI thresholds were estimated based on the ASA classification subgroups, the results yielded an inconclusive trend. The estimated MI thresholds of the patients in the “ASA I & II” group were slightly larger than for patients with “ASA II and higher”. Interestingly, the MI thresholds for subgroups clustered by LOS showed that at 12-months, TKR patients who stayed longer than seven days demanded a lower improvement in WOMAC scores (MI: 16.0 to −18.0) than patients who were discharged earlier. The achieved accuracy of MI thresholds for the patients in the TKR group was lower in comparison to the values for the patients in THR group. Also, the achieved accuracy for 3-months FU MI was lower (AUC <0.7) than for 12-months FU, which for most cases was either acceptable or excellent.

Fig. 2a and b shows the share of patients in the THR and TKR groups that achieved their unstratified (overall) and their subgroup-specific MI thresholds at 12-months FU. While the unstratified 12-months MI of 28.1 for THR patients (17.8 for TKR) would only be achieved by 0–6% (6%) of the patients included in the subgroup “0–30” (”0–20”), it would be achieved by 80–85% (80–86%) of the patients in the subgroup “61–96”. Alerts for critical recovery paths based on unstratified MI would be significantly more sensitive for patients with lower admission WOMAC total scores. On the contrary, MI thresholds estimated based on preoperative WOMAC score subgroups would lead to an even distribution of patients achieving their threshold.

Overall and stratified meaningful improvement (MI) thresholds for WOMAC total score improvements at 12-months FU for (a) the THR and (b) TKR groups.
Fig. 2 Overall and stratified meaningful improvement (MI) thresholds for WOMAC total score improvements at 12-months FU for (a) the THR and (b) TKR groups.
3.3

3.3 Patient acceptable symptom states (PASSs) thresholds

The estimated overall and stratified PASS thresholds are presented in Table 5. The unstratified PASS threshold of 13.3 for THR patients (15.4 for TKR) at 12-month FU would result in an unfair distribution of patients achieving this target (see Appendix material Figures A1 and A2). PASSs thresholds at 3- and 12-months FU were dependent on pre-operative WOMAC scores. For THR patients in the “71–96” subgroup it was already acceptable to reach a WOMAC score of 28.0 at 12-months FU, whereas THR patients in the “0–20” subgroup required a PASS of 5.0. Analogue, TKR patients in the “71–96” subgroup accepted a WOMAC score of 45.0 at 12-months FU, whereas TKR patients in the “0–20” subgroup required a PASS of 6.0 (Table 5). Similar to MI thresholds, the accuracy of estimated PASS values was higher for THR patients and at 12-months FU. The unstratified PASS values at 12-months FU were less accurate (AUCs <0.7) than the admission score group-specific PASSs (most AUCs ≥0.7).

Table 5 Estimated (overall and stratified) PASSs thresholds by FU-time for the patients in the THR and TKR groups
Total hip replacement 3 months 12 months
PASS AUC PASS AUC
Overall 14.4 0.62 13.3 0.68
Grouped by admission score
0-20 2.0 0.56 5.0 0.61
21-30 11.0 0.59 5.4 0.74
31-40 11.0 0.66 11.0 0.70
41-50 14.4 0.67 14.6 0.73
51-60 16.5 0.68 19.8 0.70
61-70 26.0 0.71 24.9 0.81
71-96 34.0 0.82 28.0 0.78
Total knee replacement
Overall 21.7 0.62 15.4 0.67
Grouped by admission score
0-20 8.0 0.60 6.0 0.63
21-30 16.4 0.64 10.9 0.70
31-40 20.0 0.70 15.0 0.66
41-50 17.0 0.63 18.3 0.74
51-60 24.0 0.69 25.0 0.73
61-70 31.0 0.68 47.0 0.73
71-96 37.0 0.79 45.0 0.92
4

4 Discussion

The implementation of a system that rewards value requires finding an accurate way to measure the outcomes that matter to patients.15 The question whether a single MI threshold is appropriate for all patients taking a particular instrument, the WOMAC total score, was not investigated yet and was addressed in this study. The objective was to calculate MI and PASS thresholds for WOMAC total score improvements after TKR and THR that are based on patient characteristics. Recovery paths and corresponding health improvements and symptom states are specific to individual characteristics of the patients. Hence, using anchor-based ROC curves, we estimated MI and PASS values for all and for subgroups of patients. The subgroups were built based on patient-specific factors like the preoperative WOMAC score. Our results indicate that the amount of WOMAC total score improvement necessary to induce an improvement in HRQoL, resulting in a benefit from surgery, is specific to preoperative patients’ characteristics. Therefore, to evaluate whether patients submitted for TKR or THR benefited from surgery, patient-specific MI thresholds should be estimated.

4.1

4.1 Study limitations

Our sample consists of patients that have responded to the WOMAC and EQ-5D-5L questionnaires at admission and 12-month post-surgery. Around 60% of THR and TKR patients treated in both hospitals were not included in the analysis because of missing PROM data in at least one of the data points. The reasons for missing data were elaborated on previously. Analyses showed that our sample of responders differed slightly from the full sample. The patients in the sample had slightly better health status at admission and less comorbidities. This source of bias, which was induced by missing PROM questionnaires, might have led to an overestimation of MI and PASS thresholds. Furthermore, our analyses were based on data of only two hospitals, a specialized endoprosthetic center and a general hospital. Moreover, we have observed that the accuracy of MI and PASS thresholds increased with the number of observations. Sample size should become more important when future studies attempt to integrate even more patient-specific factors, dividing the sample in granular subgroups.

In line with the results by Berliner et al.37 our analysis showed that admission scores can significantly predict the WOMAC score improvements, and therefore, they can be used to cluster the patients into subgroups with homogenous recovery paths. Our results showed that THR and TKR patients, who were admitted to the hospital with a better joint-related health status, experienced less improvement in WOMAC total scores but a better symptom state at 3- and 12-months FU in comparison with patients with worse preoperative joint-related health status. Not surprisingly, a generic one-size-fits-it-all approach to thresholds leads to an uneven distribution of patients achieving their corresponding MI or PASS values. Both, for patients in the THR and TKR groups, cases with high (worse) preoperative WOMAC total scores were unlikely to reach the unstratified (overall) PASS but almost all patients with higher WOMAC admission scores reached the unstratified (overall) MI thresholds. At the same time, patients with low WOMAC admission scores have a high chance to reach the unstratified PASS, but not the unstratified MI threshold. When MI and PASS thresholds for subgroups were calculated (clustered by admission WOMAC total score) the estimated thresholds were better tailored to individuals. Our results showed that THR and TKR patients with higher (worse) preoperative WOMAC total scores need more WOMAC score improvement to achieve a meaningful change in their HRQoL and consequently benefit from surgery, compared to the patients with lower WOMAC admission scores. The opposite was confirmed for PASS values. Moreover, clustering patients based on ASA classification, patients age or LOS only yielded marginally differentiated MI thresholds. The accuracy of MI and PASS thresholds was highly dependent on the sample size and samples’ homogeneity considering the recovery paths.

Various studies have investigated thresholds for joint-specific PROMs, such as the WOMAC score.8 While one study calculated multiple kinds of thresholds,26 the majority of studies concentrated on calculating MCID or PASS values, either by using an anchor-based and/or a distribution-based method. Dependent on the method used, a large variation in the MCID and PASS values could be observed. Terwee et al.38 reported MCID values for the WOMAC pain sub-score at 6-months after THR (TKR) of 8.3 (13.3) when using the distribution-based method and of 22.4 (29.4) when using anchor-based ROC curves. Moreover, McKay et al.8 described a large heterogeneity within thresholds using the anchor-based method, which depended on (1) the country in which the investigation took place,38,39 (2) the type of anchor used40 and (3) the approach used to calculate the threshold.29 Future research requires the determination of a “gold standard” method for calculating MCID/MI and PASS thresholds, without disregarding a differentiation of the threshold's goal (e.g., measuring treatment success vs. minimal improvement in health status). In the present study we have calculated MI to detect treatment success by estimating thresholds that differentiate patients that benefited from surgery from the ones who did not. Regardless, we observed that unstratified MI and PASS thresholds for the THR and TKR groups were in line with those reported in systematic reviews.8,41

However, most studies estimated unstratified MCID and PASS thresholds and did not consider that the amount of improvement necessary for a patient to benefit from surgery might vary with patient characteristics. Davis et al.42 showed that failing to take into account admission scores when calculating thresholds can result in patients being misclassified as not having benefitted from surgery. Consequently, Berliner et al.18,37 reported that the share of patients achieving an unstratified MCID depends on their admission score. Despite several studies emphasizing this effect, there is only limited literature considering it when calculating MI thresholds.43

5

5 Conclusions

Since recovery paths after THR or TKR are specific to certain patient characteristics, the full benefit of surgery for the patient can only be detected through the development of patient-specific MI and PASS thresholds. The MI and PASS thresholds clustered by the admission WOMAC total score presented in this paper, are a first step to maximize the possible impact of collecting PROMs for all stakeholders.

Ethical review committee statement

The Ethical Committee of the Federal State of Hamburg, Germany, was informed and approved this study (2021-10582-WF). The study was conducted according to the ethical standards in the 1964 Declaration of Helsinki and its later amendments.

Authors contributions

All authors contributed to the conception and design of the study. CJM, KB, KW and FL acquired the data. DK and CJM prepared the data for analyses. DK, CJM and AG analyzed and interpreted the data. DK and CJM drafted the manuscript. All authors substantively revised the work. All authors read and approved the final manuscript.

References

  1. , , , , , . Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview. BMC Muscoskel Disord. 2016;17:463.
    [Google Scholar]
  2. , , , , . Projections of primary TKA and THA in Germany from 2016 through 2040. Clin Orthop Relat Res. 2020;478:1622-1633.
    [Google Scholar]
  3. , . What is value in health care? N Engl J Med. 2010;363:2477-2481.
    [Google Scholar]
  4. , , , . Value-based healthcare: increasing value by reducing implant-related health care costs. Clin Orthop Relat Res. 2019;477:281-283.
    [Google Scholar]
  5. , , , et al . Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol : off j Am Soc Clinic Oncol. 2016;34:557-565.
    [Google Scholar]
  6. , , , , , . The use of digitally collected patient-reported outcome measures for newly operated patients with total knee and hip replacements to improve post-treatment recovery: study protocol for a randomized controlled trial. Trials. 2020;21:322.
    [Google Scholar]
  7. , , , . Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14:109-114.
    [Google Scholar]
  8. , , , , . A systematic review of estimates of the minimal clinically important difference and patient acceptable symptom state of the Western Ontario and McMaster Universities Osteoarthritis Index in patients who underwent total hip and total knee replacement. Osteoarthritis Cartilage. 2019;27:1408-1419.
    [Google Scholar]
  9. , , , . The forgotten joint score in total and unicompartmental knee arthroplasty: a prospective cohort study. Int Orthop. 2019;43:2739-2745.
    [Google Scholar]
  10. , , , , , . WOMAC, EQ-5D and knee society score thresholds for treatment success after total knee arthroplasty. J Arthroplasty. 2015;30:2154-2158.
    [Google Scholar]
  11. , , , , , , . What is the minimum clinically important difference for the WOMAC index after TKA? Clin Orthop Relat Res. 2018;476:2005-2014.
    [Google Scholar]
  12. , , , , , , . Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement. Osteoarthritis Cartilage. 2005;13:1076-1083.
    [Google Scholar]
  13. , , , et al . The WOMAC score can be reliably used to classify patient satisfaction after total knee arthroplasty. Knee Surg. Sports Traumatol. Arthrosc. : off j ESSKA. 2018;26:3333-3341.
    [Google Scholar]
  14. , . CORR insights(R): what is the minimum clinically important difference for the WOMAC index after TKA? Clin Orthop Relat Res. 2018;476:2015-2016.
    [Google Scholar]
  15. , , , . Value-based health care: moving beyond "minimum clinically important difference" to a tiered system of evaluating successful clinical outcomes. Clin Orthop Relat Res. 2019;477:945-947.
    [Google Scholar]
  16. , , , . Defining value in health care: a scoping review of the literature. Int J Qual Health Care : j Intern Soc Qual Healt Care. 2021;33
    [Google Scholar]
  17. , , , , , . TKA patients experience less improvement than THA patients at 3 and 12 months after surgery. A retrospective observational cohort study. J Orthop. 2020;21:517-522.
    [Google Scholar]
  18. , , , , , . Can preoperative patient-reported outcome measures Be used to predict meaningful improvement in function after TKA? Clin Orthop Relat Res. 2017;475:149-157.
    [Google Scholar]
  19. , , , , , . The impact of preoperative patient characteristics on health states after total hip replacement and related satisfaction thresholds: a cohort study. Health Qual Life Outcome. 2014;12:108.
    [Google Scholar]
  20. , , , et al . Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention. J Clin Epidemiol. 2015;68:518-524.
    [Google Scholar]
  21. , , , et al . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
    [Google Scholar]
  22. , , , , , . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
    [Google Scholar]
  23. , , , et al . [Evaluation of a German version of WOMAC (western Ontario and McMaster Universities) arthrosis index] Zeitschrift fur Rheumatologie. 1996;55:40-49.
    [Google Scholar]
  24. , , , . German value set for the EQ-5D-5L. Pharmacoeconomics. 2018;36:663-674.
    [Google Scholar]
  25. , , , . Measurement of health status. Ascertaining the minimal clinically important difference. Contr Clin Trials. 1989;10:407-415.
    [Google Scholar]
  26. , , , , , . What are the minimal and substantial improvements in the HOOS and KOOS and JR versions after total joint replacement? Clin Orthop Relat Res. 2018;476:2432-2441.
    [Google Scholar]
  27. , , , et al . Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann rheum dis. 2005;64:34-37.
    [Google Scholar]
  28. , , , . Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? Ann rheum dis. 2007;66(Suppl 3):iii40-41.
    [Google Scholar]
  29. , , . Using ROC curves to choose minimally important change thresholds when sensitivity and specificity are valued equally: the forgotten lesson of pythagoras. theoretical considerations and an example application of change in health status. PLoS One. 2014;9
    [Google Scholar]
  30. , , , , . Reproducibility and responsiveness of evaluative outcome measures. Theoretical considerations illustrated by an empirical example. Int J Technol Assess Health Care. 2001;17:479-487.
    [Google Scholar]
  31. , , , et al . Three ways to quantify uncertainty in individually applied "minimally important change" values. J Clin Epidemiol. 2010;63:37-45.
    [Google Scholar]
  32. , , . Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chron Dis. 1986;39:897-906.
    [Google Scholar]
  33. , , , , . Measurement in Medicine: A Practical Guide. 2011
    [Google Scholar]
  34. , . A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:171-184.
    [Google Scholar]
  35. , . Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol : official publication of the International Association for the Study of Lung Cancer. 2010;5:1315-1316.
    [Google Scholar]
  36. , , , , , . John charnley award: preoperative patient-reported outcome measures predict clinically meaningful improvement in function after THA. Clin Orthop Relat Res. 2016;474:321-329.
    [Google Scholar]
  37. , , , et al . Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63:524-534.
    [Google Scholar]
  38. , , , , . Predictors of satisfaction following total knee arthroplasty. J Arthroplasty. 2015;30:1142-1145.
    [Google Scholar]
  39. , , , , , . Willingness to go through surgery again validated the WOMAC clinically important difference from THR/TKR surgery. J Clin Epidemiol. 2008;61:907-918.
    [Google Scholar]
  40. , , , , , , . Minimum clinically important difference: current trends in the orthopaedic literature, Part II: lower extremity: a systematic review. JBJS rev. 2018;6:e2.
    [Google Scholar]
  41. , , , . Minimally clinically important improvement: all non-responders are not really non-responders an illustration from total knee replacement. Osteoarthritis Cartilage. 2012;20:364-367.
    [Google Scholar]
  42. , , , et al . The minimal clinically important difference determined using item response theory models: an attempt to solve the issue of the association with baseline score. J Clin Epidemiol. 2014;67:433-440.
    [Google Scholar]
Show Sections